Abstract
Resistance to thyroid hormone (RTH) is a rare genetic disease caused by reduced tissue sensitivity to thyroid hormone. The hallmark of RTH is elevated serum levels of thyroid hormone with unsuppressed thyrotropin (TSH). However, the most common form of RTH results from minor defects in the ligand-binding domain or hinge domain of the TRβ gene, resulting in impaired T3-induced transcriptional activity, often showing mild presentation. Early diagnosis can be challenging. The objective of the current study was to characterize this specific group of RTH patients. This was a retrospective study. Patients diagnosed as RTH with TRβ mutations were enrolled in a single institute between 2004 and 2014. A total of 14 patients were diagnosed as RTH with mutation in THβ gene. The median age at diagnosis was 22.5 (IQR: 13.25–32.75). Goiter was the most common clinical finding. TSH was significantly elevated after TRH injection (median peak was 21.83 μIU/l, IQR: 13.59–31.48), 9.2-fold compared to the basal level. We found 10 mutations in TRβ gene, all located in the last four exons, and including one novel mutation, H271D. In vitro study found that H271D mutation reduced TR affinity to T3. Four patients with intact thyroid were diagnosed after 16 years old, defined as late manifestation. Compared to those diagnosed before 10 years old, patients with late manifestation presented with normal growth and mental development. Interestingly, three of them carried R438H mutation. We identified a novel p.H271D mutation in TRβ associated with RTH. Endocrinologists should be alert that RTH is frequently found in euthyroid patients with mild symptoms and often leads to misleading diagnosis as well as inappropriate treatment.
Similar content being viewed by others
References
T. Tajima, W. Jo, K. Fujikura, M. Fukushi, K. Fujieda, Elevated free thyroxine levels detected by a neonatal screening system. Pediatr. Res. 66(3), 312–316 (2009). doi:10.1203/PDR.0b013e3181b1bcbd
P. Beck-Peccoz, V.K. Chatterjee, The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4(2), 225–232 (1994)
P. Beck-Peccoz, V.K. Chatterjee, W.W. Chin, L.J. DeGroot, J.L. Jameson, H. Nakamura, S. Refetoff, S.J. Usala, B.D. Weintraub, Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10–11, 1993, Cambridge, United Kingdom. J. Clin. Endocrinol. Metab. 78(4), 990–993 (1994). doi:10.1210/jcem.78.4.8157732
A.M. Dumitrescu, S. Refetoff, The syndromes of reduced sensitivity to thyroid hormone. Biochim. Biophys. Acta 1830(7), 3987–4003 (2013). doi:10.1016/j.bbagen.2012.08.005
C. Moran, N. Schoenmakers, M. Agostini, E. Schoenmakers, A. Offiah, A. Kydd, G. Kahaly, S. Mohr-Kahaly, O. Rajanayagam, G. Lyons, N. Wareham, D. Halsall, M. Dattani, S. Hughes, M. Gurnell, S.M. Park, K. Chatterjee, An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor alpha. J. Clin. Endocrinol. Metab. 98(11), 4254–4261 (2013). doi:10.1210/jc.2013-2215
C. Moran, M. Agostini, W.E. Visser, E. Schoenmakers, N. Schoenmakers, A.C. Offiah, K. Poole, O. Rajanayagam, G. Lyons, D. Halsall, M. Gurnell, D. Chrysis, A. Efthymiadou, C. Buchanan, S. Aylwin, K.K. Chatterjee, Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)alpha1 and TRalpha2: clinical, biochemical, and genetic analyses of three related patients. Lancet Diabetes Endocrinol. 2(8), 619–626 (2014). doi:10.1016/S2213-8587(14)70111-1
E. Bochukova, N. Schoenmakers, M. Agostini, E. Schoenmakers, O. Rajanayagam, J.M. Keogh, E. Henning, J. Reinemund, E. Gevers, M. Sarri, K. Downes, A. Offiah, A. Albanese, D. Halsall, J.W. Schwabe, M. Bain, K. Lindley, F. Muntoni, F. Vargha-Khadem, M. Dattani, I.S. Farooqi, M. Gurnell, K. Chatterjee, A mutation in the thyroid hormone receptor alpha gene. N. Engl. J. Med. 366(3), 243–249 (2012). doi:10.1056/NEJMoa1110296
S. Refetoff, R.E. Weiss, S.J. Usala, The syndromes of resistance to thyroid hormone. Endocr. Rev. 14(3), 348–399 (1993). doi:10.1210/edrv-14-3-348
P. Beck-Peccoz, A. Lania, A. Beckers, K. Chatterjee, J.L. Wemeau, 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur. Thyroid J. 2(2), 76–82 (2013). doi:10.1159/000351007
R.E. Weiss, S. Balzano, N.H. Scherberg, S. Refetoff, Neonatal detection of generalized resistance to thyroid hormone. JAMA 264(17), 2245–2250 (1990)
S.H. Lafranchi, D.B. Snyder, D.E. Sesser, M.R. Skeels, N. Singh, G.A. Brent, J.C. Nelson, Follow-up of newborns with elevated screening T4 concentrations. J. Pediatr. 143(3), 296–301 (2003). doi:10.1067/S0022-3476(03)00184-7
S.Y. Cheng, J.L. Leonard, P.J. Davis, Molecular aspects of thyroid hormone actions. Endocr. Rev. 31(2), 139–170 (2010). doi:10.1210/er.2009-0007
F. Brucker-Davis, M.C. Skarulis, M.B. Grace, J. Benichou, P. Hauser, E. Wiggs, B.D. Weintraub, Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann. Intern. Med. 123(8), 572–583 (1995)
D. Chantler, C. Moran, E. Schoenmakers, S. Cleland, M. Panarelli, Resistance to thyroid hormone–an incidental finding. BMJ Case Rep. (2012). doi:10.1136/bcr.12.2011.5375
Y. Ueda, T. Tagami, T. Tamanaha, M. Kakita, K. Tanase-Nakao, K. Nanba, T. Usui, M. Naruse, A. Shimatsu, A family of RTHbeta with p.R316C mutation presenting occasional syndrome of inappropriate secretion of TSH. Endocrine Journal (2015)
R.J. Koenig, Thyroid hormone receptor coactivators and corepressors. Thyroid 8(8), 703–713 (1998)
R.E. Weiss, C. Marcocci, G. Bruno-Bossio, S. Refetoff, Multiple genetic factors in the heterogeneity of thyroid hormone resistance. J. Clin. Endocrinol. Metab. 76(1), 257–259 (1993). doi:10.1210/jcem.76.1.8421095
I.A. Hughes, K. Ichikawa, L.J. Degroot, R. John, M.K. Jones, R. Hall, M.F. Scanlon, Non-adenomatous inappropriate TSH hypersecretion and euthyroidism requires no treatment. Clin. Endocrinol. 27(4), 475–483 (1987)
C.V. Boothroyd, B.T. Teh, N.K. Hayward, P.E. Hickman, G.J. Ward, D.P. Cameron, Single base mutation in the hormone binding domain of the thyroid hormone receptor beta gene in generalised thyroid hormone resistance demonstrated by single stranded conformation polymorphism analysis. Biochem. Biophys. Res. Commun. 178(2), 606–612 (1991)
K. Takeda, R.E. Weiss, S. Refetoff, Rapid localization of mutations in the thyroid hormone receptor-beta gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance. J. Clin. Endocrinol. Metab. 74(4), 712–719 (1992). doi:10.1210/jcem.74.4.1548332
R.E. Weiss, M. Weinberg, S. Refetoff, Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. J. Clin. Investig. 91(6), 2408–2415 (1993). doi:10.1172/JCI116474
M. Adams, C. Matthews, T.N. Collingwood, Y. Tone, P. Beck-Peccoz, K.K. Chatterjee, Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. J. Clin. Investig. 94(2), 506–515 (1994). doi:10.1172/JCI117362
M. Gurnell, O. Rajanayagam, I. Barbar, M.K. Jones, V.K. Chatterjee, Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. Thyroid 8(8), 679–682 (1998)
J.D. Safer, S.D. Colan, L.M. Fraser, F.E. Wondisford, A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 11(3), 281–291 (2001). doi:10.1089/105072501750159750
G.J. Kahaly, C.H. Matthews, S. Mohr-Kahaly, C.A. Richards, V.K. Chatterjee, Cardiac involvement in thyroid hormone resistance. J. Clin. Endocrinol. Metab. 87(1), 204–212 (2002). doi:10.1210/jcem.87.1.8170
L.F. Cardoso, F.J. de Paula, L.M. Maciel, Resistance to thyroid hormone due to mutations in the THRB gene impairs bone mass and affects calcium and phosphorus homeostasis. Bone 67, 222–227 (2014). doi:10.1016/j.bone.2014.07.017
Y. Hayashi, T. Sunthornthepvarakul, S. Refetoff, Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone. J. Clin. Investig. 94(2), 607–615 (1994). doi:10.1172/JCI117376
Compliance with ethical standards
This study was approved by the board of medical ethics of Ruijin Hospital, Shanghai Jiaotong University. Written informed consents were obtained from all patients.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Han, R., Ye, L., Jiang, X. et al. Characteristics of patients with late manifestation of resistance thyroid hormone syndrome: a single-center experience. Endocrine 50, 689–697 (2015). https://doi.org/10.1007/s12020-015-0622-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0622-x